医療用使い捨て製品の市場規模、シェア、動向分析レポート:製品別(創傷管理製品、薬物送達製品)、原材料別(プラスチック樹脂、不織布材料)、最終用途別、地域別、セグメント別予測、2023年~2030年Medical Disposables Market Size, Share & Trends Analysis Report By Product (Wound Management Products, Drug Delivery Products), By Raw Material (Plastic Resin, Nonwoven Material), By End-use, By Region, And Segment Forecasts, 2023 - 2030 医療用ディスポーザブル市場の成長と動向 Grand View Research社の最新レポートによると、世界の医療用使い捨て品市場規模は、2023年から2030年にかけて17.2%のCAGRを記録し、2030年までに1兆5,100億8,000万米... もっと見る
本レポートは受注生産のため、ご納品のお時間をいただく場合がございます。
サマリー医療用ディスポーザブル市場の成長と動向Grand View Research社の最新レポートによると、世界の医療用使い捨て品市場規模は、2023年から2030年にかけて17.2%のCAGRを記録し、2030年までに1兆5,100億8,000万米ドルに達すると予測されている。市場成長の原動力は、泌尿器疾患、癌、脳卒中、心血管疾患、慢性腎疾患、神経血管疾患などの慢性疾患の増加、高齢化人口の増加、技術の進歩、世界的な手術件数の増加、様々な最終用途施設におけるシングルユース製品の需要の増加、医療インフラへの投資の増加などである。 医療関連感染(HAI)に関連するリスクに対する一般市民の意識の高まりは、より安全な医療行為に対する需要の高まりにつながっている。患者や医療従事者は、医療現場における感染予防の重要性をますます意識するようになっている。感染伝播のリスクを減らすため、使い捨て注射器や滅菌手袋などの使い捨て医療製品の採用が広まっている。これらの製品は1回限りの使用に設計されており、患者との接触ごとに廃棄されるため、二次汚染のリスクが排除され、患者は無菌器具による治療を受けることができる。感染予防をより重視し、使い捨て医療製品を使用する方向へのこのシフトは、患者の安全性とHAIの発生を減らす必要性によって、医療行為に大きな変革が起きていることを示している。従って、このような要因により、医療用使い捨て製品の需要は近い将来増加するだろう。 医療用使い捨て製品市場レポートハイライト - 製品別では、滅菌用品セグメントが2022年の売上高シェア10.82%超で市場を独占。オートクレーブ、滅菌パウチ、化学インジケーターは、医療現場での感染管理において極めて重要な役割を果たす。 - 原材料別では、プラスチック樹脂分野が2022年に57.58%の収益シェアで市場を独占した。 - 最終用途別では、病院セグメントが53.65%の収益シェアで2022年の市場を支配した。病院は、定期検診から複雑な手術まで、幅広い医療サービスを提供しており、多くの人々にとって医療への主要なアクセスポイントとなっている。 - 地域別では、2022年に北米が約33.38%の最大の売上シェアを占めた。この地域の成長は、医療インフラが確立されていること、病院、医療施設、医療専門家の数が多いことに起因している。 目次Table of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Product 1.1.2. Raw material 1.1.3. End-use 1.1.4. Regional scope 1.1.5. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.3.5.1. Data for primary interviews in North America 1.3.5.2. Data for primary interviews in Europe 1.3.5.3. Data for primary interviews in Asia Pacific 1.3.5.4. Data for primary interviews in Latin America 1.3.5.5. Data for Primary interviews in MEA 1.4. Information or Data Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis (Model 1) 1.6.1.1. Approach 1: Commodity flow approach 1.6.2. Volume price analysis (Model 2) 1.6.2.1. Approach 2: Volume price analysis 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives 1.9.1. Objective 1 1.9.2. Objective 2 Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Product outlook 2.2.2. Raw material outlook 2.2.3. End-use outlook 2.2.4. Regional outlook 2.3. Competitive Insights Chapter 3. Medical Disposables Market Variables, Trends, & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Industry Value Chain Analysis 3.3.1. Reimbursement framework 3.4. Market Dynamics 3.4.1. Market driver analysis 3.4.1.1. Increase in number of surgical procedures 3.4.1.2. Rising incidence of Hospital Acquired Infections (HAIs) 3.4.1.3. Rising geriatric population across the globe 3.4.2. Market restraint analysis 3.4.2.1. Stringent approval norms 3.4.3. Market Opportunity Analysis 3.4.4. Market Challenge Analysis 3.5. Medical Disposables Market Analysis Tools 3.5.1. Industry Analysis - Porter’s 3.5.1.1. Supplier power 3.5.1.2. Buyer power 3.5.1.3. Substitution threat 3.5.1.4. Threat of new entrant 3.5.1.5. Competitive rivalry 3.5.2. PESTEL Analysis 3.5.2.1. Political landscape 3.5.2.2. Technological landscape 3.5.2.3. Economic landscape 3.5.3. Major Deals & Strategic Alliances Analysis 3.5.4. Market Entry Strategies Chapter 4. Medical Disposables Market: Product Estimates & Trend Analysis 4.1. Definitions and Scope 4.1.1. Wound Management Products 4.1.2. Drug Delivery Products 4.1.3. Diagnostic and Laboratory Disposables 4.1.4. Dialysis Disposables 4.1.5. Incontinence Products 4.1.6. Respiratory Supplies 4.1.7. Sterilization Supplies 4.1.8. Non-woven Disposables 4.1.9. Disposable Masks 4.1.10. Disposable Eye Gear 4.1.11. Disposable Gloves 4.1.12. Hand Sanitizers 4.1.12.1 Gel Sanitizers 4.1.12.2 Foam Sanitizers 4.1.12.3 Liquid Sanitizers 4.1.12.4 Other Sanitizers 4.1.13. Others 4.2. Product Market Share, 2022 & 2030 4.3. Segment Dashboard 4.4. Medical Disposables Market by Product Outlook 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 4.5.1. Wound Management Products 4.5.1.1. Wound management products market estimates and forecast 2018 to 2030 (USD Million) 4.5.2. Drug Delivery Products 4.5.2.1. Drug delivery products market estimates and forecast 2018 to 2030 (USD Million) 4.5.3. Diagnostic and Laboratory Disposables 4.5.3.1. Diagnostic and laboratory disposables market estimates and forecast 2018 to 2030 (USD Million) 4.5.4. Dialysis Disposables 4.5.4.1. Dialysis disposables market estimates and forecast 2018 to 2030 (USD Million) 4.5.5. Incontinence Products 4.5.5.1. Incontinence products market estimates and forecast 2018 to 2030 (USD Million) 4.5.6. Respiratory Supplies 4.5.6.1. Respiratory supplies market estimates and forecast 2018 to 2030 (USD Million) 4.5.7. Sterilization Supplies 4.5.7.1. Sterilization supplies market estimates and forecast 2018 to 2030 (USD Million) 4.5.8. Non-woven Disposables 4.5.8.1. Non-woven disposables market estimates and forecast 2018 to 2030 (USD Million) 4.5.9. Disposable Masks 4.5.9.1. Disposable masks market estimates and forecast 2018 to 2030 (USD Million) 4.5.10. Disposable Eye Gear 4.5.10.1. Disposable eye gear market estimates and forecast 2018 to 2030 (USD Million) 4.5.11. Disposable Gloves 4.5.11.1. Disposable gloves market estimates and forecast 2018 to 2030 (USD Million) 4.5.12. Hand Sanitizers 4.5.12.1. Hand sanitizers market estimates and forecast 2018 to 2030 (USD Million) 4.5.12.2. Gel Sanitizers 4.5.12.2.1 Gel sanitizers market estimates and forecast 2018 to 2030 (USD Million) 4.5.12.3. Foam Sanitizers 4.5.12.3.1 Foam sanitizers market estimates and forecast 2018 to 2030 (USD Million) 4.5.12.4. Liquid Sanitizers 4.5.12.4.1 Liquid sanitizers market estimates and forecast 2018 to 2030 (USD Million) 4.5.12.5. Others 4.5.12.5.1 Others market estimates and forecast 2018 to 2030 (USD Million) 4.5.13. Others 4.5.13.1. Others market estimates and forecast 2018 to 2030 (USD Million) Chapter 5. Medical Disposables Market: Raw Material Estimates & Trend Analysis 5.1. Definitions and Scope 5.1.1. Plastic Resin 5.1.2. Nonwoven Material 5.1.3. Rubber 5.1.4. Paper and Paperboard 5.1.5. Metals 5.1.6. Glass 5.1.7. Others 5.2. Raw material Market Share, 2022 & 2030 5.3. Segment Dashboard 5.4. Medical Disposables Market by Raw Material Outlook 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 5.5.1. Plastic Resin 5.5.1.1. Plastic resin market estimates and forecast 2018 to 2030 (USD Million) 5.5.2. Nonwoven Material 5.5.2.1. Nonwoven material market estimates and forecast 2018 to 2030 (USD Million) 5.5.3. Rubber 5.5.3.1. Rubber market estimates and forecast 2018 to 2030 (USD Million) 5.5.4. Paper and Paperboard 5.5.4.1. Paper and paperboard market estimates and forecast 2018 to 2030 (USD Million) 5.5.5. Metals 5.5.5.1. Metals market estimates and forecast 2018 to 2030 (USD Million) 5.5.6. Glass 5.5.6.1. Glass market estimates and forecast 2018 to 2030 (USD Million) 5.5.7. Others 5.5.7.1. Others market estimates and forecast 2018 to 2030 (USD Million) Chapter 6. Medical Disposables Market: End-use Estimates & Trend Analysis 6.1. Definitions and Scope 6.1.1. Hospitals 6.1.2. Home Healthcare 6.1.3. Outpatient/Primary Care Facilities 6.1.4. Others 6.2. End-use Market Share, 2022 & 2030 6.3. Segment Dashboard 6.4. Medical Disposables Market by End-use Outlook 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 6.5.1. Hospitals 6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million) 6.5.2. Home Healthcare 6.5.2.1. Home healthcare market estimates and forecast 2018 to 2030 (USD Million) 6.5.3. Outpatient/Primary Care Facilities 6.5.3.1. Outpatient/primary care facilities market estimates and forecast 2018 to 2030 (USD Million) 6.5.4. Others 6.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million) Chapter 7. Medical Disposables Market: Regional Estimates & Trend Analysis 7.1. Regional market share analysis, 2022 & 2030 7.2. Regional Market Dashboard 7.3. Global Regional Market Snapshot 7.4. Regional Market Share and Leading Players, 2022 7.4.1. North America 7.4.2. Europe 7.4.3. Asia Pacific 7.4.4. Latin America 7.4.5. Middle East and Africa 7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030 7.6. North America 7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 7.6.2. U.S. 7.6.2.1. Key country dynamics 7.6.2.2. Competitive Scenario 7.6.2.3. Regulatory framework 7.6.2.4. Reimbursement scenario 7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030 7.6.3. Canada 7.6.3.1. Key country dynamics 7.6.3.2. Competitive Scenario 7.6.3.3. Regulatory framework 7.6.3.4. Reimbursement scenario 7.6.3.5. Canada market estimates and forecasts, 2018 - 2030 7.7. Europe 7.7.1. UK 7.7.1.1. Key country dynamics 7.7.1.2. Competitive Scenario 7.7.1.3. Regulatory framework 7.7.1.4. Reimbursement scenario 7.7.1.5. UK market estimates and forecasts, 2018 - 2030 7.7.2. Germany 7.7.2.1. Key country dynamics 7.7.2.2. Competitive Scenario 7.7.2.3. Regulatory framework 7.7.2.4. Reimbursement scenario 7.7.2.5. Germany market estimates and forecasts, 2018 - 2030 7.7.3. France 7.7.3.1. Key country dynamics 7.7.3.2. Competitive Scenario 7.7.3.3. Regulatory framework 7.7.3.4. Reimbursement scenario 7.7.3.5. France market estimates and forecasts, 2018 - 2030 7.7.4. Italy 7.7.4.1. Key country dynamics 7.7.4.2. Competitive Scenario 7.7.4.3. Regulatory framework 7.7.4.4. Reimbursement scenario 7.7.4.5. Italy market estimates and forecasts, 2018 - 2030 7.7.5. Spain 7.7.5.1. Key country dynamics 7.7.5.2. Competitive Scenario 7.7.5.3. Regulatory framework 7.7.5.4. Reimbursement scenario 7.7.5.5. Spain market estimates and forecasts, 2018 - 2030 7.7.6. Denmark 7.7.6.1. Key country dynamics 7.7.6.2. Competitive Scenario 7.7.6.3. Regulatory framework 7.7.6.4. Reimbursement scenario 7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030 7.7.7. Sweden 7.7.7.1. Key country dynamics 7.7.7.2. Competitive Scenario 7.7.7.3. Regulatory framework 7.7.7.4. Reimbursement scenario 7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030 7.7.8. Norway 7.7.8.1. Key country dynamics 7.7.8.2. Competitive Scenario 7.7.8.3. Regulatory framework 7.7.8.4. Reimbursement scenario 7.7.8.5. Norway market estimates and forecasts, 2018 - 2030 7.8. Asia Pacific 7.8.1. Japan 7.8.1.1. Key country dynamics 7.8.1.2. Competitive Scenario 7.8.1.3. Regulatory framework 7.8.1.4. Reimbursement scenario 7.8.1.5. Japan market estimates and forecasts, 2018 - 2030 7.8.2. India 7.8.2.1. Key country dynamics 7.8.2.2. Competitive Scenario 7.8.2.3. Regulatory framework 7.8.2.4. Reimbursement scenario 7.8.2.5. India market estimates and forecasts, 2018 - 2030 7.8.3. China 7.8.3.1. Key country dynamics 7.8.3.2. Competitive Scenario 7.8.3.3. Regulatory framework 7.8.3.4. Reimbursement scenario 7.8.3.5. China market estimates and forecasts, 2018 - 2030 7.8.4. South Korea 7.8.4.1. Key country dynamics 7.8.4.2. Competitive Scenario 7.8.4.3. Regulatory framework 7.8.4.4. Reimbursement scenario 7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030 7.8.5. Australia 7.8.5.1. Key country dynamics 7.8.5.2. Competitive Scenario 7.8.5.3. Regulatory framework 7.8.5.4. Reimbursement scenario 7.8.5.5. Australia market estimates and forecasts, 2018 - 2030 7.8.6. Thailand 7.8.6.1. Key country dynamics 7.8.6.2. Competitive Scenario 7.8.6.3. Regulatory framework 7.8.6.4. Reimbursement scenario 7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030 7.9. Latin America 7.9.1. Brazil 7.9.1.1. Key country dynamics 7.9.1.2. Competitive Scenario 7.9.1.3. Regulatory framework 7.9.1.4. Reimbursement scenario 7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030 7.9.2. Mexico 7.9.2.1. Key country dynamics 7.9.2.2. Competitive Scenario 7.9.2.3. Regulatory framework 7.9.2.4. Reimbursement scenario 7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030 7.9.3. Argentina 7.9.3.1. Key country dynamics 7.9.3.2. Competitive Scenario 7.9.3.3. Regulatory framework 7.9.3.4. Reimbursement scenario 7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030 7.10. MEA 7.10.1. South Africa 7.10.1.1. Key country dynamics 7.10.1.2. Competitive Scenario 7.10.1.3. Regulatory framework 7.10.1.4. Reimbursement scenario 7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030 7.10.2. Saudi Arabia 7.10.2.1. Key country dynamics 7.10.2.2. Competitive Scenario 7.10.2.3. Regulatory framework 7.10.2.4. Reimbursement scenario 7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 7.10.3. UAE 7.10.3.1. Key country dynamics 7.10.3.2. Competitive Scenario 7.10.3.3. Regulatory framework 7.10.3.4. Reimbursement scenario 7.10.3.5. UAE market estimates and forecasts, 2018 - 2030 7.10.4. Kuwait 7.10.4.1. Key country dynamics 7.10.4.2. Competitive Scenario 7.10.4.3. Regulatory framework 7.10.4.4. Reimbursement scenario 7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030 Chapter 8. Competitive Landscape 8.1. Recent Developments & Impact Analysis, By Key Market Participants 8.2. Company/Competition Categorization 8.2.1. Innovators 8.3. Vendor Landscape 8.3.1. List of key distributors and channel partners 8.3.2. Key customers 8.3.3. Key company market share analysis, 2022 8.3.4. Medline Industries, Inc. 8.3.4.1. Company overview 8.3.4.2. Financial performance 8.3.4.3. Product benchmarking 8.3.4.4. Strategic initiatives 8.3.5. Smith & Nephew PLC 8.3.5.1. Company overview 8.3.5.2. Financial performance 8.3.5.3. Product benchmarking 8.3.5.4. Strategic initiatives 8.3.6. Bayer AG 8.3.6.1. Company overview 8.3.6.2. Financial performance 8.3.6.3. Product benchmarking 8.3.6.4. Strategic initiatives 8.3.7. BD 8.3.7.1. Company overview 8.3.7.2. Financial performance 8.3.7.3. Product benchmarking 8.3.7.4. Strategic initiatives 8.3.8. 3M 8.3.8.1. Company overview 8.3.8.2. Financial performance 8.3.8.3. Product benchmarking 8.3.8.4. Strategic initiatives 8.3.9. Cardinal Health 8.3.9.1. Company overview 8.3.9.2. Financial performance 8.3.9.3. Product benchmarking 8.3.9.4. Strategic initiatives
SummaryMedical Disposables Market Growth & Trends Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Product 1.1.2. Raw material 1.1.3. End-use 1.1.4. Regional scope 1.1.5. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.3.5.1. Data for primary interviews in North America 1.3.5.2. Data for primary interviews in Europe 1.3.5.3. Data for primary interviews in Asia Pacific 1.3.5.4. Data for primary interviews in Latin America 1.3.5.5. Data for Primary interviews in MEA 1.4. Information or Data Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis (Model 1) 1.6.1.1. Approach 1: Commodity flow approach 1.6.2. Volume price analysis (Model 2) 1.6.2.1. Approach 2: Volume price analysis 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives 1.9.1. Objective 1 1.9.2. Objective 2 Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Product outlook 2.2.2. Raw material outlook 2.2.3. End-use outlook 2.2.4. Regional outlook 2.3. Competitive Insights Chapter 3. Medical Disposables Market Variables, Trends, & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Industry Value Chain Analysis 3.3.1. Reimbursement framework 3.4. Market Dynamics 3.4.1. Market driver analysis 3.4.1.1. Increase in number of surgical procedures 3.4.1.2. Rising incidence of Hospital Acquired Infections (HAIs) 3.4.1.3. Rising geriatric population across the globe 3.4.2. Market restraint analysis 3.4.2.1. Stringent approval norms 3.4.3. Market Opportunity Analysis 3.4.4. Market Challenge Analysis 3.5. Medical Disposables Market Analysis Tools 3.5.1. Industry Analysis - Porter’s 3.5.1.1. Supplier power 3.5.1.2. Buyer power 3.5.1.3. Substitution threat 3.5.1.4. Threat of new entrant 3.5.1.5. Competitive rivalry 3.5.2. PESTEL Analysis 3.5.2.1. Political landscape 3.5.2.2. Technological landscape 3.5.2.3. Economic landscape 3.5.3. Major Deals & Strategic Alliances Analysis 3.5.4. Market Entry Strategies Chapter 4. Medical Disposables Market: Product Estimates & Trend Analysis 4.1. Definitions and Scope 4.1.1. Wound Management Products 4.1.2. Drug Delivery Products 4.1.3. Diagnostic and Laboratory Disposables 4.1.4. Dialysis Disposables 4.1.5. Incontinence Products 4.1.6. Respiratory Supplies 4.1.7. Sterilization Supplies 4.1.8. Non-woven Disposables 4.1.9. Disposable Masks 4.1.10. Disposable Eye Gear 4.1.11. Disposable Gloves 4.1.12. Hand Sanitizers 4.1.12.1 Gel Sanitizers 4.1.12.2 Foam Sanitizers 4.1.12.3 Liquid Sanitizers 4.1.12.4 Other Sanitizers 4.1.13. Others 4.2. Product Market Share, 2022 & 2030 4.3. Segment Dashboard 4.4. Medical Disposables Market by Product Outlook 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 4.5.1. Wound Management Products 4.5.1.1. Wound management products market estimates and forecast 2018 to 2030 (USD Million) 4.5.2. Drug Delivery Products 4.5.2.1. Drug delivery products market estimates and forecast 2018 to 2030 (USD Million) 4.5.3. Diagnostic and Laboratory Disposables 4.5.3.1. Diagnostic and laboratory disposables market estimates and forecast 2018 to 2030 (USD Million) 4.5.4. Dialysis Disposables 4.5.4.1. Dialysis disposables market estimates and forecast 2018 to 2030 (USD Million) 4.5.5. Incontinence Products 4.5.5.1. Incontinence products market estimates and forecast 2018 to 2030 (USD Million) 4.5.6. Respiratory Supplies 4.5.6.1. Respiratory supplies market estimates and forecast 2018 to 2030 (USD Million) 4.5.7. Sterilization Supplies 4.5.7.1. Sterilization supplies market estimates and forecast 2018 to 2030 (USD Million) 4.5.8. Non-woven Disposables 4.5.8.1. Non-woven disposables market estimates and forecast 2018 to 2030 (USD Million) 4.5.9. Disposable Masks 4.5.9.1. Disposable masks market estimates and forecast 2018 to 2030 (USD Million) 4.5.10. Disposable Eye Gear 4.5.10.1. Disposable eye gear market estimates and forecast 2018 to 2030 (USD Million) 4.5.11. Disposable Gloves 4.5.11.1. Disposable gloves market estimates and forecast 2018 to 2030 (USD Million) 4.5.12. Hand Sanitizers 4.5.12.1. Hand sanitizers market estimates and forecast 2018 to 2030 (USD Million) 4.5.12.2. Gel Sanitizers 4.5.12.2.1 Gel sanitizers market estimates and forecast 2018 to 2030 (USD Million) 4.5.12.3. Foam Sanitizers 4.5.12.3.1 Foam sanitizers market estimates and forecast 2018 to 2030 (USD Million) 4.5.12.4. Liquid Sanitizers 4.5.12.4.1 Liquid sanitizers market estimates and forecast 2018 to 2030 (USD Million) 4.5.12.5. Others 4.5.12.5.1 Others market estimates and forecast 2018 to 2030 (USD Million) 4.5.13. Others 4.5.13.1. Others market estimates and forecast 2018 to 2030 (USD Million) Chapter 5. Medical Disposables Market: Raw Material Estimates & Trend Analysis 5.1. Definitions and Scope 5.1.1. Plastic Resin 5.1.2. Nonwoven Material 5.1.3. Rubber 5.1.4. Paper and Paperboard 5.1.5. Metals 5.1.6. Glass 5.1.7. Others 5.2. Raw material Market Share, 2022 & 2030 5.3. Segment Dashboard 5.4. Medical Disposables Market by Raw Material Outlook 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 5.5.1. Plastic Resin 5.5.1.1. Plastic resin market estimates and forecast 2018 to 2030 (USD Million) 5.5.2. Nonwoven Material 5.5.2.1. Nonwoven material market estimates and forecast 2018 to 2030 (USD Million) 5.5.3. Rubber 5.5.3.1. Rubber market estimates and forecast 2018 to 2030 (USD Million) 5.5.4. Paper and Paperboard 5.5.4.1. Paper and paperboard market estimates and forecast 2018 to 2030 (USD Million) 5.5.5. Metals 5.5.5.1. Metals market estimates and forecast 2018 to 2030 (USD Million) 5.5.6. Glass 5.5.6.1. Glass market estimates and forecast 2018 to 2030 (USD Million) 5.5.7. Others 5.5.7.1. Others market estimates and forecast 2018 to 2030 (USD Million) Chapter 6. Medical Disposables Market: End-use Estimates & Trend Analysis 6.1. Definitions and Scope 6.1.1. Hospitals 6.1.2. Home Healthcare 6.1.3. Outpatient/Primary Care Facilities 6.1.4. Others 6.2. End-use Market Share, 2022 & 2030 6.3. Segment Dashboard 6.4. Medical Disposables Market by End-use Outlook 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 6.5.1. Hospitals 6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million) 6.5.2. Home Healthcare 6.5.2.1. Home healthcare market estimates and forecast 2018 to 2030 (USD Million) 6.5.3. Outpatient/Primary Care Facilities 6.5.3.1. Outpatient/primary care facilities market estimates and forecast 2018 to 2030 (USD Million) 6.5.4. Others 6.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million) Chapter 7. Medical Disposables Market: Regional Estimates & Trend Analysis 7.1. Regional market share analysis, 2022 & 2030 7.2. Regional Market Dashboard 7.3. Global Regional Market Snapshot 7.4. Regional Market Share and Leading Players, 2022 7.4.1. North America 7.4.2. Europe 7.4.3. Asia Pacific 7.4.4. Latin America 7.4.5. Middle East and Africa 7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030 7.6. North America 7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 7.6.2. U.S. 7.6.2.1. Key country dynamics 7.6.2.2. Competitive Scenario 7.6.2.3. Regulatory framework 7.6.2.4. Reimbursement scenario 7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030 7.6.3. Canada 7.6.3.1. Key country dynamics 7.6.3.2. Competitive Scenario 7.6.3.3. Regulatory framework 7.6.3.4. Reimbursement scenario 7.6.3.5. Canada market estimates and forecasts, 2018 - 2030 7.7. Europe 7.7.1. UK 7.7.1.1. Key country dynamics 7.7.1.2. Competitive Scenario 7.7.1.3. Regulatory framework 7.7.1.4. Reimbursement scenario 7.7.1.5. UK market estimates and forecasts, 2018 - 2030 7.7.2. Germany 7.7.2.1. Key country dynamics 7.7.2.2. Competitive Scenario 7.7.2.3. Regulatory framework 7.7.2.4. Reimbursement scenario 7.7.2.5. Germany market estimates and forecasts, 2018 - 2030 7.7.3. France 7.7.3.1. Key country dynamics 7.7.3.2. Competitive Scenario 7.7.3.3. Regulatory framework 7.7.3.4. Reimbursement scenario 7.7.3.5. France market estimates and forecasts, 2018 - 2030 7.7.4. Italy 7.7.4.1. Key country dynamics 7.7.4.2. Competitive Scenario 7.7.4.3. Regulatory framework 7.7.4.4. Reimbursement scenario 7.7.4.5. Italy market estimates and forecasts, 2018 - 2030 7.7.5. Spain 7.7.5.1. Key country dynamics 7.7.5.2. Competitive Scenario 7.7.5.3. Regulatory framework 7.7.5.4. Reimbursement scenario 7.7.5.5. Spain market estimates and forecasts, 2018 - 2030 7.7.6. Denmark 7.7.6.1. Key country dynamics 7.7.6.2. Competitive Scenario 7.7.6.3. Regulatory framework 7.7.6.4. Reimbursement scenario 7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030 7.7.7. Sweden 7.7.7.1. Key country dynamics 7.7.7.2. Competitive Scenario 7.7.7.3. Regulatory framework 7.7.7.4. Reimbursement scenario 7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030 7.7.8. Norway 7.7.8.1. Key country dynamics 7.7.8.2. Competitive Scenario 7.7.8.3. Regulatory framework 7.7.8.4. Reimbursement scenario 7.7.8.5. Norway market estimates and forecasts, 2018 - 2030 7.8. Asia Pacific 7.8.1. Japan 7.8.1.1. Key country dynamics 7.8.1.2. Competitive Scenario 7.8.1.3. Regulatory framework 7.8.1.4. Reimbursement scenario 7.8.1.5. Japan market estimates and forecasts, 2018 - 2030 7.8.2. India 7.8.2.1. Key country dynamics 7.8.2.2. Competitive Scenario 7.8.2.3. Regulatory framework 7.8.2.4. Reimbursement scenario 7.8.2.5. India market estimates and forecasts, 2018 - 2030 7.8.3. China 7.8.3.1. Key country dynamics 7.8.3.2. Competitive Scenario 7.8.3.3. Regulatory framework 7.8.3.4. Reimbursement scenario 7.8.3.5. China market estimates and forecasts, 2018 - 2030 7.8.4. South Korea 7.8.4.1. Key country dynamics 7.8.4.2. Competitive Scenario 7.8.4.3. Regulatory framework 7.8.4.4. Reimbursement scenario 7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030 7.8.5. Australia 7.8.5.1. Key country dynamics 7.8.5.2. Competitive Scenario 7.8.5.3. Regulatory framework 7.8.5.4. Reimbursement scenario 7.8.5.5. Australia market estimates and forecasts, 2018 - 2030 7.8.6. Thailand 7.8.6.1. Key country dynamics 7.8.6.2. Competitive Scenario 7.8.6.3. Regulatory framework 7.8.6.4. Reimbursement scenario 7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030 7.9. Latin America 7.9.1. Brazil 7.9.1.1. Key country dynamics 7.9.1.2. Competitive Scenario 7.9.1.3. Regulatory framework 7.9.1.4. Reimbursement scenario 7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030 7.9.2. Mexico 7.9.2.1. Key country dynamics 7.9.2.2. Competitive Scenario 7.9.2.3. Regulatory framework 7.9.2.4. Reimbursement scenario 7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030 7.9.3. Argentina 7.9.3.1. Key country dynamics 7.9.3.2. Competitive Scenario 7.9.3.3. Regulatory framework 7.9.3.4. Reimbursement scenario 7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030 7.10. MEA 7.10.1. South Africa 7.10.1.1. Key country dynamics 7.10.1.2. Competitive Scenario 7.10.1.3. Regulatory framework 7.10.1.4. Reimbursement scenario 7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030 7.10.2. Saudi Arabia 7.10.2.1. Key country dynamics 7.10.2.2. Competitive Scenario 7.10.2.3. Regulatory framework 7.10.2.4. Reimbursement scenario 7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 7.10.3. UAE 7.10.3.1. Key country dynamics 7.10.3.2. Competitive Scenario 7.10.3.3. Regulatory framework 7.10.3.4. Reimbursement scenario 7.10.3.5. UAE market estimates and forecasts, 2018 - 2030 7.10.4. Kuwait 7.10.4.1. Key country dynamics 7.10.4.2. Competitive Scenario 7.10.4.3. Regulatory framework 7.10.4.4. Reimbursement scenario 7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030 Chapter 8. Competitive Landscape 8.1. Recent Developments & Impact Analysis, By Key Market Participants 8.2. Company/Competition Categorization 8.2.1. Innovators 8.3. Vendor Landscape 8.3.1. List of key distributors and channel partners 8.3.2. Key customers 8.3.3. Key company market share analysis, 2022 8.3.4. Medline Industries, Inc. 8.3.4.1. Company overview 8.3.4.2. Financial performance 8.3.4.3. Product benchmarking 8.3.4.4. Strategic initiatives 8.3.5. Smith & Nephew PLC 8.3.5.1. Company overview 8.3.5.2. Financial performance 8.3.5.3. Product benchmarking 8.3.5.4. Strategic initiatives 8.3.6. Bayer AG 8.3.6.1. Company overview 8.3.6.2. Financial performance 8.3.6.3. Product benchmarking 8.3.6.4. Strategic initiatives 8.3.7. BD 8.3.7.1. Company overview 8.3.7.2. Financial performance 8.3.7.3. Product benchmarking 8.3.7.4. Strategic initiatives 8.3.8. 3M 8.3.8.1. Company overview 8.3.8.2. Financial performance 8.3.8.3. Product benchmarking 8.3.8.4. Strategic initiatives 8.3.9. Cardinal Health 8.3.9.1. Company overview 8.3.9.2. Financial performance 8.3.9.3. Product benchmarking 8.3.9.4. Strategic initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
Grand View Research社の医療機器分野での最新刊レポート
本レポートと同じKEY WORD(drug)の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/18 10:27 154.74 円 162.88 円 199.42 円 |